dihydroergocryptine has been researched along with tolcapone in 1 studies
| Studies (dihydroergocryptine) | Trials (dihydroergocryptine) | Recent Studies (post-2010) (dihydroergocryptine) | Studies (tolcapone) | Trials (tolcapone) | Recent Studies (post-2010) (tolcapone) |
|---|---|---|---|---|---|
| 21 | 8 | 2 | 413 | 82 | 132 |
| Protein | Taxonomy | dihydroergocryptine (IC50) | tolcapone (IC50) |
|---|---|---|---|
| Transthyretin | Homo sapiens (human) | 3.2 | |
| Catechol O-methyltransferase | Homo sapiens (human) | 0.043 | |
| Catechol O-methyltransferase | Rattus norvegicus (Norway rat) | 0.4661 | |
| Adenosine receptor A2a | Homo sapiens (human) | 0.93 | |
| Genome polyprotein | Dengue virus 2 Thailand/16681/84 | 0.64 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goetz, CG; Poewe, W; Rascol, O; Sampaio, C | 1 |
1 review(s) available for dihydroergocryptine and tolcapone
| Article | Year |
|---|---|
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone | 2005 |